• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p-ANCAs 在自身免疫性肝病中识别人类β-微管蛋白同工型 5 并与微生物蛋白 FtsZ 发生交叉反应。

p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ.

机构信息

Department of Internal Medicine, University of Bonn, Sigmund-Freud-Strasse 25, Bonn D-53105, Germany.

出版信息

Gut. 2010 Jun;59(6):808-16. doi: 10.1136/gut.2008.157818. Epub 2009 Dec 1.

DOI:10.1136/gut.2008.157818
PMID:19951907
Abstract

OBJECTIVE

Autoimmune hepatitis and primary sclerosing cholangitis are chronic inflammatory disorders of unknown aetiology, frequently associated with the presence of perinuclear antineutrophil cytoplasmic antibodies (p-ANCAs) directed against an unknown antigen of myeloid cells.

METHODS AND RESULTS

Here, it is reported that p-ANCAs in autoimmune liver disorders react with beta-tubulin isotype 5 (TBB-5) as autoantigen as well as with its evolutionary bacterial precursor protein FtsZ. Both proteins were confirmed as antigens of p-ANCAs in autoimmune liver disorders by demonstrating reactivity of ANCA-positive sera with recombinant TBB-5 (72-88%) and FtsZ (64-82%) on immunoblots and antigen-specific abrogation of ANCA immunofluorescence when sera had been preabsorbed with tubulin and FtsZ. Using sera from interleukin 10-deficient mice (Il10(-)/(-)), an animal model of inflammatory bowel disease, it was also demonstrated that antibodies against TBB-5 are generated in response to intestinal microorganisms. However, unlike autoimmune liver disorders, human antibodies to FtsZ in the absence of TBB-5 antibodies were also a frequent finding in non-autoimmune liver diseases (up to 95%). Reactivity to TBB-5 without the presence of FtsZ antibodies was found in very few cases (<1%) in autoimmune liver disorders.

CONCLUSIONS

Thus, p-ANCAs in autoimmune liver diseases are directed against human TBB-5 cross-reacting with the bacterial protein FtsZ, probably reflecting an abnormal immune response to intestinal microorganisms in susceptible, possibly genetically predisposed individuals.

摘要

目的

自身免疫性肝炎和原发性硬化性胆管炎是病因不明的慢性炎症性疾病,常伴有核周抗中性粒细胞胞浆抗体(p-ANCAs),该抗体针对髓样细胞的未知抗原。

方法和结果

本研究报道,自身免疫性肝疾病中的 p-ANCAs 不仅与β-微管蛋白异构体 5(TBB-5)作为自身抗原发生反应,还与进化细菌前体蛋白 FtsZ 发生反应。通过证明 ANCA 阳性血清与重组 TBB-5(72-88%)和 FtsZ(64-82%)在免疫印迹上的反应性,以及当血清用微管蛋白和 FtsZ 预吸收时 ANCA 免疫荧光的抗原特异性阻断,证实了这两种蛋白均为自身免疫性肝疾病 p-ANCAs 的抗原。使用白细胞介素 10 缺陷小鼠(Il10(-)/(-))的血清,一种炎症性肠病的动物模型,也证明了针对 TBB-5 的抗体是针对肠道微生物产生的。然而,与自身免疫性肝疾病不同,在没有 TBB-5 抗体的情况下,人类针对 FtsZ 的抗体也是非自身免疫性肝疾病(高达 95%)的常见发现。在自身免疫性肝疾病中,很少有病例(<1%)出现仅对 TBB-5 有反应而无 FtsZ 抗体的情况。

结论

因此,自身免疫性肝疾病中的 p-ANCAs 针对人类 TBB-5,与细菌蛋白 FtsZ 发生交叉反应,可能反映了对易感、可能存在遗传易感性个体的肠道微生物的异常免疫反应。

相似文献

1
p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ.p-ANCAs 在自身免疫性肝病中识别人类β-微管蛋白同工型 5 并与微生物蛋白 FtsZ 发生交叉反应。
Gut. 2010 Jun;59(6):808-16. doi: 10.1136/gut.2008.157818. Epub 2009 Dec 1.
2
Immune reactivity to β-tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders.自身免疫性胃肠疾病患者对β-微管蛋白同型5和囊泡整合膜蛋白36的免疫反应性。
Gut. 2011 Nov;60(11):1601-2. doi: 10.1136/gut.2010.222646. Epub 2010 Dec 15.
3
Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.原发性胆汁性肝硬化中的抗中性粒细胞核抗体(ANNA):其患病率及抗原特异性。
Z Gastroenterol. 1997 Feb;35(2):113-21.
4
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.自身免疫性肝病中中性粒细胞胞浆抗体的患病率及特征
Hepatology. 1993 Mar;17(3):411-7.
5
Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?原发性硬化性胆管炎和自身免疫性肝炎中的非典型核周型抗中性粒细胞胞浆抗体:指向“肠屏障功能障碍”的线索?
Clin Rev Allergy Immunol. 2009 Feb;36(1):40-51. doi: 10.1007/s12016-008-8088-8.
6
Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.采用ROC曲线和多因素回归分析评估非典型抗中性粒细胞胞浆抗体在自身免疫性肝炎中的诊断准确性
Eur J Med Res. 2004 Sep 29;9(9):439-48.
7
Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).慢性肝病患者的抗中性粒细胞胞浆抗体:自身免疫性肝病诊断的患病率、抗原特异性及预测价值。瑞典内科肝脏俱乐部(SILK)。
J Gastroenterol Hepatol. 2000 Apr;15(4):437-42. doi: 10.1046/j.1440-1746.2000.02078.x.
8
Relevance of the inner mitochondrial membrane enzyme F1F0-ATPase as an autoantigen in autoimmune liver disorders.线粒体膜酶 F1F0-ATP 合酶作为自身抗原在自身免疫性肝疾病中的相关性。
Liver Int. 2012 Feb;32(2):249-57. doi: 10.1111/j.1478-3231.2011.02630.x. Epub 2011 Sep 8.
9
Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis.与人类中性粒细胞弹性蛋白酶反应的抗中性粒细胞胞浆抗体作为可卡因诱导的中线破坏性病变而非自身免疫性血管炎的诊断标志物。
Arthritis Rheum. 2004 Sep;50(9):2954-65. doi: 10.1002/art.20479.
10
Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins.慢性炎症性肠病和肝胆疾病中具有核周荧光的非典型抗中性粒细胞胞浆抗体与核纤层蛋白共定位。
Hepatology. 1998 Aug;28(2):332-40. doi: 10.1002/hep.510280207.

引用本文的文献

1
Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.应对炎症性肠病和原发性硬化性胆管炎中的肿瘤风险
Cancers (Basel). 2025 Jun 27;17(13):2165. doi: 10.3390/cancers17132165.
2
The causal impact of genetically predicted inflammatory bowel disease on extraintestinal manifestations: a mendelian randomization study.基因预测的炎症性肠病对肠外表现的因果影响:一项孟德尔随机化研究。
BMC Gastroenterol. 2025 Mar 4;25(1):135. doi: 10.1186/s12876-024-03566-4.
3
Tubulin beta 5 is not the target of antineutrophil antibodies in primary sclerosing cholangitis.
微管蛋白β5不是原发性硬化性胆管炎中抗中性粒细胞抗体的靶点。
Clin Exp Immunol. 2024 Sep 16;218(1):75-77. doi: 10.1093/cei/uxae053.
4
Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview.自身免疫性肝炎:诊断与治疗概述
Diagnostics (Basel). 2024 Feb 9;14(4):382. doi: 10.3390/diagnostics14040382.
5
Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitis.严重急性胆管炎患者血浆和胆汁中微生物群衍生的促凋亡肽corisin水平升高。
Gut Pathog. 2023 Nov 30;15(1):59. doi: 10.1186/s13099-023-00587-4.
6
An overview of recent treatment options for primary sclerosing cholangitis.原发性硬化性胆管炎近期治疗方案概述
Ann Gastroenterol. 2023 Nov-Dec;36(6):589-598. doi: 10.20524/aog.2023.0834. Epub 2023 Oct 30.
7
Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.自身免疫性肝病中β微管蛋白自身抗体——与核周型抗中性粒细胞胞浆抗体的关系及临床相关性
Clin Exp Immunol. 2024 Apr 23;216(2):146-158. doi: 10.1093/cei/uxad114.
8
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives.自身免疫性肝病与多发性硬化症:现状与未来展望。
Clin Exp Med. 2023 Nov;23(7):3321-3338. doi: 10.1007/s10238-023-01128-8. Epub 2023 Jul 8.
9
PR3-ANCAs Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis.通过第三代酶联免疫吸附测定法检测到的抗蛋白酶3抗中性粒细胞胞浆抗体可预测原发性硬化性胆管炎的严重疾病和不良生存情况。
Diagnostics (Basel). 2022 Nov 3;12(11):2682. doi: 10.3390/diagnostics12112682.
10
The microbiota and the gut-liver axis in primary sclerosing cholangitis.原发性硬化性胆管炎中的微生物群与肠-肝轴
Nat Rev Gastroenterol Hepatol. 2023 Mar;20(3):135-154. doi: 10.1038/s41575-022-00690-y. Epub 2022 Nov 9.